Enhanced Healthcare Partners and Bourne Partners Exit PAI Pharma
Deal News | Feb 24, 2025 | Enhanced Management Co LLC
Enhanced Healthcare Partners (EHP) and Bourne Partners Strategic Capital (BPSC) have successfully completed the sale of their investment in PAI Pharma to Olympus Partners. PAI Pharma, a leader in the development, manufacturing, and distribution of generic oral liquid medicines, has significantly expanded its facilities and infrastructure in recent years. Operating from New Jersey and South Carolina, PAI serves a diverse range of healthcare facilities. The sale marks a strategic exit for EHP and BPSC, who have facilitated PAI's growth over the past years. The financial terms of the transaction remain undisclosed, but RBC Capital Markets and Bourne Partners served as financial advisors. EHP and BPSC are both private equity firms specializing in the healthcare sector, with a focus on collaborative growth with management teams.
Sectors
- Healthcare
- Private Equity
- Pharmaceutical Manufacturing
Geography
- United States – The primary operating locations of PAI Pharma are in New Jersey and South Carolina.
Industry
- Healthcare – Related to the development, manufacturing, and distribution of generic oral liquids by PAI Pharma.
- Private Equity – Involves the sale and acquisition of PAI Pharma by private equity firms EHP and BPSC.
- Pharmaceutical Manufacturing – PAI Pharma's industry as a manufacturer and distributor of generic medicines.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Enhanced Healthcare Partners | Seller | Company | A healthcare-focused private equity firm involved in the sale of PAI Pharma. |
| Bourne Partners Strategic Capital | Seller | Company | A private equity firm specializing in pharmaceutical sectors, also involved in the sale of PAI Pharma. |
| PAI Pharma | Target Company | Company | The company sold, known for manufacturing and distributing generic oral liquid medicines. |
| Olympus Partners | Buyer | Company | The company that acquired PAI Pharma. |
| RBC Capital Markets, LLC | Financial Advisor | Company | Served as a financial advisor to PAI Pharma on the sale. |
| Bourne Partners | Financial Advisor | Company | Also acted as financial advisor for PAI Pharma in the transaction. |
| Kurt Orlofski | CEO | Person | CEO of PAI Pharma. |
| Matt Thompson | General Partner | Person | General Partner at Enhanced Healthcare Partners. |
| Minor Hinson | Head of Private Equity | Person | Head of Private Equity at Bourne Partners Strategic Capital. |
| Banks Bourne | Founder | Person | Founder of Bourne Partners and Bourne Partners Strategic Capital. |